Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmiths Group Regulatory News (SMIN)

Share Price Information for Smiths Group (SMIN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,717.00
Bid: 1,712.00
Ask: 1,714.00
Change: 19.00 (1.12%)
Spread: 2.00 (0.117%)
Open: 1,699.00
High: 1,717.00
Low: 1,699.00
Prev. Close: 1,698.00
SMIN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

17 Nov 2015 07:00

RNS Number : 9146F
Smiths Group PLC
17 November 2015
 

 

 

News Release

London, 17 November 2015

For immediate release

 

 

SMITHS GROUP PLC TRADING STATEMENT

 

Key points

· Resilient first quarter performance, reflecting mixed end-markets.

· Group revenue declined by 4% compared to the same quarter last year.1

· Group operating margin broadly in line with the same period last year.

· Cash conversion continued to be strong.

· Expectations for the full year remain broadly unchanged.

· Significant progress in pension funding delivers £36 million increase in annual free cash flow.

 

 

Commenting on Smiths Group's performance in the three months to 1 November, Chief Executive Andy Reynolds Smith said:

 

"Overall, we have made a resilient start to the year. While persistently tough oil and gas end markets have impacted John Crane, we saw good profitability growth in Detection and performance in line with our expectations at Smiths Medical, Interconnect and Flex-Tek."

 

"Since recently joining Smiths, I have visited major locations for each of our divisions and met with our top teams. I am pleased by the quality of what I have seen, including our technology capabilities, strong market positions and talented people. I believe there is clear potential to further improve our operational performance across the business, giving us the flexibility to respond with speed to customer and market demands."

 

"Against a backdrop of challenging conditions in some of our end-markets, our expectations for the full year remain broadly unchanged."

 

First quarter commentary

The impact of challenging oil and gas markets was partially offset by relative stability in the Group's other core markets. Underlying revenues for the first quarter at John Crane were, as expected, below the same quarter last year. This continued the trend seen towards the end of the prior year, where sales to First Fit customers continued to be very challenging, while aftermarket revenues were more resilient. Smiths Detection continued to deliver improved profitability in the quarter, supported by recent contract wins and a stronger order book. Smiths Medical recorded a solid performance in the quarter, with underlying revenue consistent with last year. Performance at Smiths Interconnect and Flex-Tek in the quarter was broadly similar to last year.

 

In a separate announcement today, Smiths confirmed material improvements in its funding plan for the Smiths Industries Pension Scheme ("SIPS"). This includes a significant reduction in the actuarial deficit and will result in a £36 million annualised increase in free cash flow by 2017.

 

____________ 

1 Underlying revenue at constant currency.

 

ENDS

 

This press release contains certain forward-looking statements with respect to the operations, performance and financial condition of the Group. By their nature, these statements involve uncertainty since future events and circumstances can cause results and developments to differ materially from those anticipated. The forward-looking statements reflect knowledge and information available at the date of preparation of the press release and the Company undertakes no obligation to update these forward-looking statements. Nothing in this press release should be construed as a profit forecast.

 

 

Investor Relations

Andrew Lappin: +44 (0)20 7808 5557

 

Media Relations

Colin McSeveny: +44 (0)20 7808 5534

Anthony Cardew - Cardew Group: +44 (0)20 7930 0777

 

Smiths Group

Smiths is a global technology company listed on the London Stock Exchange (SMIN) and operates a sponsored level one ADR programme (SMGZY). A world leader in the practical application of advanced technologies, Smiths Group delivers products and services for the threat & contraband detection, medical devices, energy and communications markets worldwide. Our products and services make the world safer, healthier and more productive. Smiths Group employs around 23,000 people in over 50 countries. For more information visit www.smiths.com

 
This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFFLFAMFISELF
Date   Source Headline
20th Jun 20247:00 amRNSTransaction in Own Shares
19th Jun 20247:00 amRNSTransaction in Own Shares
18th Jun 20247:00 amRNSTransaction in Own Shares
17th Jun 20247:00 amRNSTransaction in Own Shares
14th Jun 20247:00 amRNSTransaction in Own Shares
13th Jun 20247:00 amRNSTransaction in Own Shares
12th Jun 20247:00 amRNSTransaction in Own Shares
11th Jun 20247:00 amRNSTransaction in Own Shares
10th Jun 20247:00 amRNSTransaction in Own Shares
7th Jun 20247:00 amRNSTransaction in Own Shares
6th Jun 20247:00 amRNSTransaction in Own Shares
5th Jun 20247:00 amRNSTransaction in Own Shares
4th Jun 20247:00 amRNSTransaction in Own Shares
3rd Jun 20243:35 pmRNSTotal Voting Rights
3rd Jun 202410:00 amRNSDirectorate Change
3rd Jun 20247:00 amRNSTransaction in Own Shares
31st May 20247:00 amRNSTransaction in Own Shares
21st May 20247:00 amRNSSmiths Group 3rd Quarter Results
16th May 20249:30 amRNSDirector/PDMR Shareholding
8th May 20247:00 amRNSTransaction in Own Shares
7th May 20247:00 amRNSTransaction in Own Shares
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20247:00 amRNSTransaction in Own Shares
1st May 20244:45 pmRNSDirector/PDMR Shareholding
1st May 20243:30 pmRNSTotal Voting Rights
1st May 202410:00 amRNSBlock listing Interim Review
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20249:00 amRNSDirector/PDMR Shareholding
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20244:30 pmRNSTotal Voting Rights
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:15 amRNSShare buyback programme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.